Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo

A Corrigendum to this article was published on 25 August 2005

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1

References

  1. Duan J et al. Hum Mol Genet 2003; 12: 205–216.

  2. Noble EP . Am J Med Genet 2003; 116B: 103–125.

  3. Farde L et al. Synapse 1995; 20 (3): 200–208.

  4. Pohjalainen T et al. Mol Psychiatry 1998; 3: 256–260.

    CAS  Article  Google Scholar 

  5. Hietala J et al. Arch Gen Psychiatry 1994; 51: 116–123.

    CAS  Article  Google Scholar 

  6. Laakso A et al. Pharmacogenetics, (in press)..

  7. Dubertret C et al. Schizophr Res 2004; 67 (1): 75–85.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Hietala.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hirvonen, M., Laakso, A., Någren, K. et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9, 1060–1061 (2004). https://doi.org/10.1038/sj.mp.4001561

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001561

Further reading

Search

Quick links